Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients

Many patients have advanced esophageal cancer at diagnosis. However, the most optimal treatment has not been identified. Therefore, we evaluated a weekly regimen of carboplatin (area under the curve (AUC)) of 4 and paclitaxel at 100 mg/m(2) as an induction or palliative treatment. All patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: de Man, Femke M., van Eerden, Ruben A.G., Oomen-de Hoop, Esther, Veraart, Joris N., van Doorn, Nadia, van Doorn, Leni, van der Gaast, Ate, Mathijssen, Ron H.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627268/
https://www.ncbi.nlm.nih.gov/pubmed/31200588
http://dx.doi.org/10.3390/cancers11060826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627268/
https://www.ncbi.nlm.nih.gov/pubmed/31200588
http://dx.doi.org/10.3390/cancers11060826

Ejemplares similares